DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500–515

Article  PubMed  Google Scholar 

Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG (2018) Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 7(4):379–403

Article  PubMed  PubMed Central  Google Scholar 

McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213–5219

Article  PubMed  PubMed Central  Google Scholar 

Johnson AR, Fleishman A, Granoff MD, Shillue K, Houlihan MJ, Sharma R et al (2021) Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg 147(3):373e-e381

Article  CAS  PubMed  Google Scholar 

Fallahian F, Tadisina KK, Xu KY (2022) Efficacy of microsurgical treatment of primary lymphedema. Ann Plast Surg 88(2):195–199

Article  CAS  PubMed  Google Scholar 

Chang DW, Suami H, Skoracki R (2013) A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 132(5):1305–1314

Article  CAS  PubMed  Google Scholar 

Boccardo F, Casabona F, de Cian F, Friedman D, Villa G, Bogliolo S et al (2009) Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 16(3):703–708

Article  PubMed  Google Scholar 

Boccardo F, Casabona F, DeCian F, Friedman D, Murelli F, Puglisi M et al (2014) Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery 34(6):421–424

Article  PubMed  Google Scholar 

Schwarz GS, Grobmyer SR, Djohan RS, Cakmakoglu C, Bernard SL, Radford D et al (2019) Axillary reverse mapping and lymphaticovenous bypass: lymphedema prevention through enhanced lymphatic visualization and restoration of flow. J Surg Oncol 120(2):160–7

PubMed  Google Scholar 

Hahamoff M, Gupta N, Munoz D, Lee BT, Clevenger P, Shaw C et al (2019) A lymphedema surveillance program for breast cancer patients reveals the promise of surgical prevention. J Surg Res 244:604–611

Article  PubMed  Google Scholar 

Feldman S, Bansil H, Ascherman J, Grant R, Borden B, Henderson P et al (2015) Single institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol 22(10):3296–3301

Article  PubMed  Google Scholar 

Ozmen T, Lazaro M, Zhou Y, Vinyard A, Avisar E (2019) Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection. Ann Surg 270(6):1156–1160

Article  PubMed  Google Scholar 

Coriddi M, Dayan J, Mehrara B (2020) Nomenclature in lymphedema surgery. Plast Reconstr Surg 146(3):385e-e386

Article  CAS  PubMed  Google Scholar 

Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK et al (2010) A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543–8

PubMed  Google Scholar 

Liu S, Wang N, Gao P, Liu P, Yang H, Xie F et al (2020) Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. World J Surg Oncol 18(1):118

Article  PubMed  PubMed Central  Google Scholar 

Schunemann E, Dória MT, Silvestre JBCH, Gasperin P, Cavalcanti TCS, Budel VM (2014) Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol 21(7):2197–2202

Article  PubMed  PubMed Central  Google Scholar 

Gennaro M, Listorti C, Mariani L, Maccauro M, Bianchi G, Capri G et al (2021) Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer. Eur J Surg Oncol 47(7):1606–1610

Article  PubMed  Google Scholar 

Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS (2014) Axillary reverse mapping: five-year experience. Surgery 156(5):1261–1268

Article  PubMed  Google Scholar 

Abdelhamid MI, Bari AA, Farid MI, Nour H (2020) Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - randomised controlled trial. Int J Surg 75:174–178

Article  PubMed  Google Scholar 

Shaffer K, Cakmakoglu C, Schwarz GS, ElSherif A, Al-Hilli Z, Djohan R et al (2020) Lymphedema prevention surgery: improved operating efficiency over time. Ann Surg Oncol 27(12):4695–4701

Article  PubMed  Google Scholar 

Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS et al (2008) Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 206(5):1038–42 (discussion 1042-4)

Article  PubMed  Google Scholar 

Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P et al (2008) Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 15(9):2550–2555

Article  PubMed  Google Scholar 

Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC et al (2007) Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 14(6):1890–1895

Article  PubMed  Google Scholar 

McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK et al (2014) Locoregional recurrence risk for patients with T1,2 breast cancer with 1–3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol*Biol*Phys 89(2):392–8

Article  PubMed  Google Scholar 

Castaneda CA, Rebaza P, Castillo M, Gomez HL, de La Cruz M, Calderon G et al (2018) Critical review of axillary recurrence in early breast cancer. Crit Rev Oncol Hematol 129:146–152

Article  PubMed  Google Scholar 

Smidt ML, Janssen CMM, Kuster DM, Bruggink EDM, Strobbe LJA (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 12(1):29–33

Article  PubMed  Google Scholar 

van der Ploeg IMC, Nieweg OE, van Rijk MC, Valdés Olmos RA, Kroon BBR (2008) Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34(12):1277–1284

Article  PubMed  Google Scholar 

Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C et al (2016) Survival impact and predictive factors of axillary recurrence after sentinel biopsy. Eur J Cancer 58:73–82

Article  PubMed  Google Scholar 

Wangchinda P, Ithimakin S (2016) Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer. World J Surg Oncol 14(1):223

Article  PubMed  PubMed Central  Google Scholar 

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P et al (2017) 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. NEJM 377(19):1836–1846

Article  PubMed  Google Scholar 

Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Thürlimann B et al (2016) Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol 34(9):927–935

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colzani E, Johansson AL, Liljegren A, Foukakis T, Clements M, Adolfsson J et al (2014) Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer 110(5):1378–84

Article  CAS  PubMed  PubMed Central  Google Scholar